Peter G. Steinherz, MD | Authors

Comentary (Steinherz): Toxicity of CNS Prophylaxis for Childhood Leukemia

February 01, 1997

Over the past 20 years, dramatic improvements have been made in the treatment of childhood malignancies. Today, most children who have cancer are expected to survive their disease and become healthy, productive members of society. Children with acute lymphoblastic leukemia (ALL) are a good example. Although pediatric ALL was an invariably fatal disorder in the past, children with this cancer now have a 5-year event-free survival rate of more than 70%.